Pentostatin for treatment of steroid-refractory acute GVHD: a retrospective single-center analysis

Acute GVHD (aGVHD) remains a major cause of mortality in patients undergoing allo-SCT. In particular, the outcome of those patients who fail first-line therapy with glucocorticosteroids is poor. Preliminary reports suggested that the purine analogue pentostatin might be effective for treatment of st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmitt, Thomas (VerfasserIn) , Luft, Thomas (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Tran, Thuong Hien (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Dreger, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2011]
In: Bone marrow transplantation
Year: 2011, Jahrgang: 46, Heft: 4, Pages: 580-585
ISSN:1476-5365
DOI:10.1038/bmt.2010.146
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bmt.2010.146
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bmt2010146
Volltext
Verfasserangaben:T. Schmitt, T. Luft, U. Hegenbart, T.H. Tran, A.D. Ho and P. Dreger

MARC

LEADER 00000caa a2200000 c 4500
001 1818807297
003 DE-627
005 20230710111309.0
007 cr uuu---uuuuu
008 221012s2011 xx |||||o 00| ||eng c
024 7 |a 10.1038/bmt.2010.146  |2 doi 
035 |a (DE-627)1818807297 
035 |a (DE-599)KXP1818807297 
035 |a (OCoLC)1389769822 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmitt, Thomas  |d 1980-  |e VerfasserIn  |0 (DE-588)13302928X  |0 (DE-627)530941902  |0 (DE-576)265846404  |4 aut 
245 1 0 |a Pentostatin for treatment of steroid-refractory acute GVHD  |b a retrospective single-center analysis  |c T. Schmitt, T. Luft, U. Hegenbart, T.H. Tran, A.D. Ho and P. Dreger 
264 1 |c [2011] 
300 |b 1 Diagramm 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 21 June 2010 
500 |a Gesehen am 12.10.2022 
520 |a Acute GVHD (aGVHD) remains a major cause of mortality in patients undergoing allo-SCT. In particular, the outcome of those patients who fail first-line therapy with glucocorticosteroids is poor. Preliminary reports suggested that the purine analogue pentostatin might be effective for treatment of steroid-refractory aGVHD. Here, we report on our single-center experience with pentostatin in this condition. From 2005 to 2008, a total of 24 consecutive patients, who had undergone first-line salvage treatment for steroid-refractory aGVHD of the gastrointestinal tract with pentostatin, were identified from 301 patients allografted during that period and retrospectively analyzed. Response to treatment, defined as CR or very good PR (VGPR), was observed in nine patients (38%), with a median time to response of 10 days. Although pentostatin was associated with only moderate myelosuppressive toxicity, if any, 2-year survival was only 17% with five of the nine responders dying from infection (four patients) or recurrent GVHD (one patient). We conclude that pentostatin is a moderately effective therapy for steroid-refractory aGVHD, showing response and outcome rates similar to other clinically used regimens. 
650 4 |a Drug therapy 
650 4 |a Graft-versus-host disease 
700 1 |a Luft, Thomas  |e VerfasserIn  |0 (DE-588)1078976309  |0 (DE-627)839996969  |0 (DE-576)452120659  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Tran, Thuong Hien  |d 1965-  |e VerfasserIn  |0 (DE-588)113498128  |0 (DE-627)691186030  |0 (DE-576)171410513  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 46(2011), 4, Seite 580-585  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Pentostatin for treatment of steroid-refractory acute GVHD a retrospective single-center analysis 
773 1 8 |g volume:46  |g year:2011  |g number:4  |g pages:580-585  |g extent:6  |a Pentostatin for treatment of steroid-refractory acute GVHD a retrospective single-center analysis 
856 4 0 |u https://doi.org/10.1038/bmt.2010.146  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bmt2010146  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221012 
993 |a Article 
994 |a 2011 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 113498128  |a Tran, Thuong Hien  |m 113498128:Tran, Thuong Hien  |d 910000  |d 911600  |e 910000PT113498128  |e 911600PT113498128  |k 0/910000/  |k 1/910000/911600/  |p 4 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1078976309  |a Luft, Thomas  |m 1078976309:Luft, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PL1078976309  |e 910100PL1078976309  |e 50000PL1078976309  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 2 
998 |g 13302928X  |a Schmitt, Thomas  |m 13302928X:Schmitt, Thomas  |d 50000  |e 50000PS13302928X  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1818807297  |e 4196534422 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"pubHistory":["Nachgewiesen 19.1997 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320433366","disp":"Pentostatin for treatment of steroid-refractory acute GVHD a retrospective single-center analysisBone marrow transplantation","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2004030-1"],"issn":["1476-5365"],"eki":["320433366"]},"part":{"pages":"580-585","year":"2011","text":"46(2011), 4, Seite 580-585","volume":"46","issue":"4","extent":"6"},"note":["Gesehen am 17.01.25"],"origin":[{"publisherPlace":"London ; Basingstoke ; London","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group"}],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}]}],"note":["Published: 21 June 2010","Gesehen am 12.10.2022"],"physDesc":[{"noteIll":"1 Diagramm","extent":"6 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1818807297"],"doi":["10.1038/bmt.2010.146"]},"language":["eng"],"title":[{"subtitle":"a retrospective single-center analysis","title_sort":"Pentostatin for treatment of steroid-refractory acute GVHD","title":"Pentostatin for treatment of steroid-refractory acute GVHD"}],"person":[{"family":"Schmitt","display":"Schmitt, Thomas","given":"Thomas","role":"aut"},{"role":"aut","family":"Luft","display":"Luft, Thomas","given":"Thomas"},{"family":"Hegenbart","given":"Ute","display":"Hegenbart, Ute","role":"aut"},{"family":"Tran","given":"Thuong Hien","display":"Tran, Thuong Hien","role":"aut"},{"display":"Ho, Anthony Dick","given":"Anthony Dick","family":"Ho","role":"aut"},{"role":"aut","family":"Dreger","display":"Dreger, Peter","given":"Peter"}],"recId":"1818807297","origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"[2011]"}],"name":{"displayForm":["T. Schmitt, T. Luft, U. Hegenbart, T.H. Tran, A.D. Ho and P. Dreger"]}} 
SRT |a SCHMITTTHOPENTOSTATI2011